[Bio USA] Samsung Biologics unveils new platform at Bio USA
By Kim Hae-yeon Korea Herald correspondent SAN DIEGO -- Leading contract development and manufacturing organization Samsung Biologics has introduced a new contract development platform with a customized strategy to enhance its competitive edge in the market. At the 2024 Bio International Convention's opening event on Monday, Samsung Biologics introduced S-Tensify, its new platform designed to support the development of high-concentration biopharmaceuticals through advanced culture technol
June 4, 2024